Cancer Epidemiology (CE) The goal of the Cancer Epidemiology (CE) Program is to provide a platform to synergize research efforts of epidemiologic and clinical researchers in order to elucidate pathways to cancer occurrence and progression that can impact clinical treatment and prevention strategies. The program brings together experienced, NCI- funded epidemiologists, molecular biologists, biostatisticians, bioinformaticists and NCCC clinicians around 3 central interactive program themes: (1) population genomics, (2) emerging risk factors, and (3) life course epidemiology. Program investigators design, execute, and analyze population-based research aimed at understanding cancer etiology, second malignancies, progression, and survival, as well as develop novel methods for these lines of research. This work is based on outstanding efforts to use population-based studies of the catchment area population and also to engage in research with national and international epidemiologic resources, including clinical trials, cohort and case-control studies. Currently there are 22 members, including 3 clinical members and 1 joint member, spanning 11 departments with expertise and experience in all facets of modern molecular epidemiology. The NCCC has been instrumental in supporting the efforts of the CE program, most notably with its support of strategic, targeted recruitment efforts, including the recruitment of Chris Amos, Olga Gorlova, Jennifer Doherty, Diane Gilbert-Diamond, Scott Williams, Amarendra Das, Zhigang Li, Brock Christensen and Carmen Marsit, the latter who serves now as Co-Director of the program with Margaret Karagas. Spurred by these recruitments and their synergies with existing member interests, the present program has developed and evolved, from a broader program in Cancer Epidemiology and Chemoprevention, to focus its efforts on cancer epidemiology research and translation. The program aims to expand collaborative research efforts within its membership and across NCCC Programs, utilizing monthly program meetings to encourage these activities, which are subsequently catalyzed by pilot grants funded by NCCC. The support of the NCCC was paramount in the successful creation and funding of the new COBRE Center for Molecular Epidemiology, the development of an interdisciplinary training program in the Quantitative Population Sciences in Cancer, and a second COBRE in Integrative Biology. These initiatives have been instrumental in the recruitment of talented faculty and trainees that continue to energize and grow cancer epidemiology research. More than 580 cancer-related articles have been published over the reporting period (85 [15%] in high impact journals), with all 22 members on intra-program (158=27%) and 19 members on inter- program (74=13%) collaborations. Total funding for the program is currently $11.5M, of which $10.8M is peer- reviewed and $2.9M is from NCI. These efforts will allow the CE program to continue to perform cutting-edge molecular epidemiologic research, on the etiology and outcomes of cancer, to reduce the burden of human malignancies and impact prevention and treatment strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-40
Application #
9616828
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
40
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Lin, Anping; Yin, Juan; Cheng, Chao et al. (2018) Decreased expression of FOXA2 promotes eutopic endometrial cell proliferation and migration in patients with endometriosis. Reprod Biomed Online 36:181-187
Elder, David E; Piepkorn, Michael W; Barnhill, Raymond L et al. (2018) Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation. J Am Acad Dermatol 79:52-59.e5
Rutter, Carolyn M; Kim, Jane J; Meester, Reinier G S et al. (2018) Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev 27:158-164
Kumar, Nishant; Tafe, Laura J; Higgins, John H et al. (2018) Identifying Associations between Somatic Mutations and Clinicopathologic Findings in Lung Cancer Pathology Reports. Methods Inf Med 57:63-73
Punshon, Tracy; Jackson, Brian P (2018) Essential micronutrient and toxic trace element concentrations in gluten containing and gluten-free foods. Food Chem 252:258-264
Pernas, Sonia; Martin, Miguel; Kaufman, Peter A et al. (2018) Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial. Lancet Oncol 19:812-824
Svedbom, Axel; Borgström, Fredrik; Hernlund, Emma et al. (2018) Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS. Qual Life Res 27:707-716
Skolasky, Richard L; Scherer, Emily A; Wegener, Stephen T et al. (2018) Does reduction in sciatica symptoms precede improvement in disability and physical health among those treated surgically for intervertebral disc herniation? Analysis of temporal patterns in data from the Spine Patient Outcomes Research Trial. Spine J 18:1318-1324
Doubeni, Chyke A; Gabler, Nicole B; Wheeler, Cosette M et al. (2018) Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin 68:199-216
Sites, Brian D; Harrison, Jordon; Herrick, Michael D et al. (2018) Prescription Opioid Use and Satisfaction With Care Among Adults With Musculoskeletal Conditions. Ann Fam Med 16:6-13

Showing the most recent 10 out of 1911 publications